Skip to main content

Table 1 Baseline characteristics of clinical E. faecium isolates

From: The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS)

N total

35,906

 

Year of sampling

 2012 (n, %)

4139

11.53

 2013 (n, %)

5452

15.18

 2014 (n, %)

6326

17.62

 2015 (n, %)

6932

19.31

 2016 (n, %)

6806

18.96

 2017 (n, %)

6251

17.41

Gender of patient

 Female (n, %)

17,892

49.83

 Male (n, %)

15,370

42.81

 NA (n, %)

2644

7.36

 Sex ratio (f/m)

1.16

 

Age of patient

 0–19 yrs. (n, %)

527

1.47

 20–39 yrs. (n, %)

1183

3.29

 40–59 yrs. (n, %)

5547

15.45

 60–79 yrs. (n, %)

17,785

49.53

 80+ yrs. (n, %)

10,864

30.26

 Age (median, IQR)

74.0

63.0–81.0

Specimen (sampling site)

 Blood (n, %)

3011

8.39

 Urine (n, %)

16,261

45.29

 Swab (n, %)

5687

15.84

 Wound (n, %)

5550

15.46

 Other (n, %)

5280

14.71

 NA (n, %)

117

0.33

Region

 Southwest (n, %)

11,868

33.05

 Southeast (n, %)

395

1.10

 West (n, %)

19,508

54.33

 Northwest (n, %)

2400

6.68

 Northeast (n, %)

1594

4.44

 NA (n, %)

141

0.39

Hospital care type

 Secondary care (n, %)

31,182

86.84

 Tertiary care (n, %)

3283

9.14

 Specialist care

1109

3.09

 Prevention and rehabilitation care (n, %)

158

0.44

 Other (n, %)

33

0.09

 NA (n, %)

141

0.39

 Hospitals (n)

148

 

 Patients (n)

33,643

Â